WHO Chief Scientist, Soumya Swaminathan amid the race of Covid-19 vaccine globally, with dozens in clinical trials hopes for initial inoculations this year and said that mass shot for the successful vaccine will be unlikely. She stated that the people with most difficulties and at high risks will be given the first advantages, such as health care workers, and front-line workers, the elderly, and so on. She adds, “A healthy young person might have to wait until 2022.”

Johnson & Johnson and AstraZeneca’s US trial’s two candidates have been paused due to safety concerns. The bigger concern in the coming future will be to manufacture billions of doses of an eventual successful vaccine and also to decide who will be getting the first doses. WHO also warned against the complacency in the increasing mortality rate. Furthermore, Swaminathan said that case tallies are rising tremendously in the intensive care units.

He further said, “We shouldn’t be complacent that death rates are coming down, as it will lag behind increasing cases”. Also, the head of the WHO warned earlier and said that herd immunity strategy can be realistic but people need to stop being unethical. 

Tedros Adhanom Ghebreyesus, Director-General of WHO stated that all the health officials are aiming at herd immunity, and to do that almost 95% of the population needs to be immunized. Also, the WHO believes that less than 10% of the entire population is immune to the virus, which keeps the rest susceptible.


Please enter your comment!
Please enter your name here